Literature DB >> 20021999

Loss-of-function mutations in the PRPS1 gene cause a type of nonsyndromic X-linked sensorineural deafness, DFN2.

Xuezhong Liu1, Dongyi Han, Jianzhong Li, Bing Han, Xiaomei Ouyang, Jing Cheng, Xu Li, Zhanguo Jin, Youqin Wang, Maria Bitner-Glindzicz, Xiangyin Kong, Heng Xu, Albena Kantardzhieva, Roland D Eavey, Christine E Seidman, Jonathan G Seidman, Li L Du, Zheng-Yi Chen, Pu Dai, Maikun Teng, Denise Yan, Huijun Yuan.   

Abstract

We report a large Chinese family with X-linked postlingual nonsyndromic hearing impairment in which the critical linkage interval spans a genetic distance of 5.41 cM and a physical distance of 15.1 Mb that overlaps the DFN2 locus. Mutation screening of the PRPS1 gene in this family and in the three previously reported DFN2 families identified four different missense mutations in PRPS1. These mutations result in a loss of phosphoribosyl pyrophosphate (PRPP) synthetase 1 activity, as was shown in silico by structural analysis and was shown in vitro by enzymatic activity assays in erythrocytes and fibroblasts from patients. By in situ hybridization, we demonstrate expression of Prps1 in murine vestibular and cochlea hair cells, with continuous expression in hair cells and postnatal expression in the spiral ganglion. Being the second identified gene associated with X-linked nonsyndromic deafness, PRPS1 will be a good candidate gene for genetic testing for X-linked nonsyndromic hearing loss. 2010 The American Society of Human Genetics. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20021999      PMCID: PMC2801751          DOI: 10.1016/j.ajhg.2009.11.015

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  18 in total

1.  Cloning of two distinct copies of human phosphoribosylpyrophosphate synthetase cDNA.

Authors:  B J Roessler; G Bell; S Heidler; S Seino; M Becker; T D Palella
Journal:  Nucleic Acids Res       Date:  1990-01-11       Impact factor: 16.971

2.  An inborn error of purine metabolism, deafness and neurodevelopmental abnormality.

Authors:  H A Simmonds; D R Webster; S Lingam; J Wilson
Journal:  Neuropediatrics       Date:  1985-05       Impact factor: 1.947

3.  Structural basis for the function of Bacillus subtilis phosphoribosyl-pyrophosphate synthetase.

Authors:  T A Eriksen; A Kadziola; A K Bentsen; K W Harlow; S Larsen
Journal:  Nat Struct Biol       Date:  2000-04

4.  Mutant feedback-resistant phosphoribosylpyrophosphate synthetase associated with purine overproduction and gout. Phosphoribosylpyrophosphate and purine metabolism in cultured fibroblasts.

Authors:  E Zoref; A De Vries; O Sperling
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

5.  Inherited superactivity of phosphoribosylpyrophosphate synthetase: association of uric acid overproduction and sensorineural deafness.

Authors:  M A Becker; J G Puig; F A Mateos; M L Jimenez; M Kim; H A Simmonds
Journal:  Am J Med       Date:  1988-09       Impact factor: 4.965

6.  The genetic and functional basis of purine nucleotide feedback-resistant phosphoribosylpyrophosphate synthetase superactivity.

Authors:  M A Becker; P R Smith; W Taylor; R Mustafi; R L Switzer
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

7.  Sex linked deafness: Wilde revisited.

Authors:  W Reardon
Journal:  J Med Genet       Date:  1990-06       Impact factor: 6.318

8.  Human X-linked phosphoribosylpyrophosphate synthetase superactivity is associated with distinct point mutations in the PRPS1 gene.

Authors:  B J Roessler; J M Nosal; P R Smith; S A Heidler; T D Palella; R L Switzer; M A Becker
Journal:  J Biol Chem       Date:  1993-12-15       Impact factor: 5.157

9.  Mutations in PRPS1, which encodes the phosphoribosyl pyrophosphate synthetase enzyme critical for nucleotide biosynthesis, cause hereditary peripheral neuropathy with hearing loss and optic neuropathy (cmtx5).

Authors:  Hee-Jin Kim; Kwang-Min Sohn; Michael E Shy; Karen M Krajewski; Miok Hwang; June-Hee Park; Sue-Yon Jang; Hong-Hee Won; Byung-Ok Choi; Sung Hwa Hong; Byoung-Joon Kim; Yeon-Lim Suh; Chang-Seok Ki; Soo-Youn Lee; Sun-Hee Kim; Jong-Won Kim
Journal:  Am J Hum Genet       Date:  2007-06-29       Impact factor: 11.025

10.  Association between X-linked mixed deafness and mutations in the POU domain gene POU3F4.

Authors:  Y J de Kok; S M van der Maarel; M Bitner-Glindzicz; I Huber; A P Monaco; S Malcolm; M E Pembrey; H H Ropers; F P Cremers
Journal:  Science       Date:  1995-02-03       Impact factor: 47.728

View more
  39 in total

1.  Novel autosomal recessive nonsyndromic hearing impairment locus DFNB90 maps to 7p22.1-p15.3.

Authors:  Ghazanfar Ali; Kwanghyuk Lee; Paula B Andrade; Sulman Basit; Regie Lyn P Santos-Cortez; Leon Chen; Musharraf Jelani; Muhammad Ansar; Wasim Ahmad; Suzanne M Leal
Journal:  Hum Hered       Date:  2011-07-06       Impact factor: 0.444

Review 2.  A novel mutation in gene of PRPS1 in a young Chinese woman with X-linked gout: a case report and review of the literature.

Authors:  Bo-Yun Yang; Han-Xiao Yu; Jie Min; Xiao-Xiao Song
Journal:  Clin Rheumatol       Date:  2019-11-26       Impact factor: 2.980

Review 3.  PRPS1 mutations: four distinct syndromes and potential treatment.

Authors:  Arjan P M de Brouwer; Hans van Bokhoven; Sander B Nabuurs; Willem Frans Arts; John Christodoulou; John Duley
Journal:  Am J Hum Genet       Date:  2010-04-09       Impact factor: 11.025

4.  Cellular resolution maps of X chromosome inactivation: implications for neural development, function, and disease.

Authors:  Hao Wu; Junjie Luo; Huimin Yu; Amir Rattner; Alisa Mo; Yanshu Wang; Philip M Smallwood; Bracha Erlanger; Sarah J Wheelan; Jeremy Nathans
Journal:  Neuron       Date:  2014-01-08       Impact factor: 17.173

5.  Mutations in PRPS1 causing syndromic or nonsyndromic hearing impairment: intrafamilial phenotypic variation complicates genetic counseling.

Authors:  Marta Gandía; Joaquín Fernández-Toral; Juan Solanellas; María Domínguez-Ruiz; Elena Gómez-Rosas; Francisco J Del Castillo; Manuela Villamar; Miguel A Moreno-Pelayo; Ignacio Del Castillo
Journal:  Pediatr Res       Date:  2015-03-18       Impact factor: 3.756

6.  Functional characterization of a novel loss-of-function mutation of PRPS1 related to early-onset progressive nonsyndromic hearing loss in Koreans (DFNX1): Potential implications on future therapeutic intervention.

Authors:  So Young Kim; Ah Reum Kim; Nayoung K D Kim; Chung Lee; Jin Hee Han; Min Young Kim; Eun-Hee Jeon; Woong-Yang Park; Rahul Mittal; Denise Yan; Xue Zhong Liu; Byung Yoon Choi
Journal:  J Gene Med       Date:  2016-11       Impact factor: 4.565

Review 7.  Phosphoribosyl Diphosphate (PRPP): Biosynthesis, Enzymology, Utilization, and Metabolic Significance.

Authors:  Bjarne Hove-Jensen; Kasper R Andersen; Mogens Kilstrup; Jan Martinussen; Robert L Switzer; Martin Willemoës
Journal:  Microbiol Mol Biol Rev       Date:  2016-12-28       Impact factor: 11.056

8.  Novel form of X-linked nonsyndromic hearing loss with cochlear malformation caused by a mutation in the type IV collagen gene COL4A6.

Authors:  Simone Rost; Elisa Bach; Cordula Neuner; Indrajit Nanda; Sandra Dysek; Reginald E Bittner; Alexander Keller; Oliver Bartsch; Robert Mlynski; Thomas Haaf; Clemens R Müller; Erdmute Kunstmann
Journal:  Eur J Hum Genet       Date:  2013-05-29       Impact factor: 4.246

9.  Phosphoribosylpyrophosphate Synthetase 1 Knockdown Suppresses Tumor Formation of Glioma CD133+ Cells Through Upregulating Cell Apoptosis.

Authors:  Chen Li; Zhongjie Yan; Xuhua Cao; Xiaowei Zhang; Liang Yang
Journal:  J Mol Neurosci       Date:  2016-06-25       Impact factor: 3.444

10.  Cytoplasmic mislocalization of POU3F4 due to novel mutations leads to deafness in humans and mice.

Authors:  Thomas Parzefall; Shaked Shivatzki; Danielle R Lenz; Birgit Rathkolb; Kathy Ushakov; Daphne Karfunkel; Yisgav Shapira; Michael Wolf; Manuela Mohr; Eckhard Wolf; Sibylle Sabrautzki; Martin Hrabé de Angelis; Moshe Frydman; Zippora Brownstein; Karen B Avraham
Journal:  Hum Mutat       Date:  2013-05-08       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.